GW Pharmaceuticals (GWPH)
Was the period between Sept 20 and 28 a market overreaction? Either case, GWPH finds itself once again in the range that preceded it, with resistance (1) at 149.40 and support (2) at 137.27. A steep short-term downtrend couched within a 6-month uptrend, if we were to take a bearish forecast, even for the short-term, note that should price break above resistance at (1), that it can still reach above point (3) and still be within potential correction range favoring the downside.
The risk of loss in the trading of stocks, options, futures, forex, foreign equities, and bonds can be substantial and is not suitable for all investors. Trading on margin or the use of leverage is not suitable for all investors and losses exceeding your initial deposit is possible. Supporting documentation is available upon request. Trading futures, options on futures, and FX involves substantial risk of loss and is not suitable for all investors. Carefully consider whether trading is suitable for you in light of your circumstances, knowledge, and financial resources and only risk capital should be used. Opinions, market data, and recommendations are subject to change at any time. The lower the margin used the higher the leverage and therefore increases your risk. Past performance is not necessarily indicative of future results.